NEO NeoGenomics, Inc. - Common Stock

NASDAQ · Health Care · View on SEC EDGAR ↗
$16.21
Price · Aug 18, 2026
Fundamentals as of Jul 28, 2026

About NeoGenomics, Inc. - Common Stock Company overview from Wikipedia

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Read more

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

## History

NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.

In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.

In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.

In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.

In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

NEO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$16.21
Market Cap
$2.10B
P/E (TTM)
-68.3
EPS (TTM)
Revenue (TTM)
$727M
Div Yield
ROE
-12.8%
Debt/Equity
0.4
52W Range
$6 – $17

NEO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $727M
10-point trend, +213.8%
2016-12-31 2025-12-31
EPS
Free Cash Flow $-22M
8-point trend, -601.0%
2017-12-31 2025-12-31
Margins -14.8%
7-point trend, -10.3%
2019-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NEO
Peer Median
P/E (TTM)
5-point trend, +65.5%
-68.3
32.1
P/S (TTM)
5-point trend, -73.8%
2.9
0.8
P/B
5-point trend, -47.8%
2.5
2.0
EV / EBITDA
4-point trend, -104.3%
-19.7
Price / FCF
5-point trend, -64.4%
-96.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NEO
Peer Median
Gross Margin
5-point trend, +11.9%
43.2%
27.6%
Operating Margin
5-point trend, +35.0%
-15.9%
Net Profit Margin
5-point trend, -763.4%
-14.8%
0.79%
ROA
5-point trend, -1143.1%
-7.2%
1.3%
ROE
5-point trend, -1627.0%
-12.8%
3.9%
ROIC
5-point trend, -62.4%
-9.6%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NEO
Peer Median
Debt / Equity
4-point trend, -25.5%
0.4
Current Ratio
5-point trend, -45.5%
4.3
1.3
Quick Ratio
5-point trend, -26.6%
3.6

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NEO
Peer Median
Revenue YoY
5-point trend, +50.2%
10.1%
Revenue CAGR 3Y
5-point trend, +50.2%
12.6%
Revenue CAGR 5Y
5-point trend, +50.2%
10.3%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NEO
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NEO
Peer Median

NEO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 16 analysts
  • Strong Buy 4 25.0%
  • Buy 7 43.8%
  • Hold 5 31.2%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

9 analysts · 2026-08-14
Median target $19.00 +17.2%
Mean target $19.72 +21.7%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.01%
Period EPS Actual EPS Est Surprise
June 30, 2026 $0.05 $0.03 0.02%
March 31, 2026 $0.01 $0.01 0.00%
Dec. 31, 2025 $0.06 $0.04 0.02%
Sept. 30, 2025 $0.03 $0.02 0.01%
June 30, 2025 $0.03 $0.02 0.01%
March 31, 2025 $0.00 $-0.01 0.01%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NEO $1.51B -49.0 10.1% -14.8% -12.8% 43.2%
AVAH $1.70B 7.7 20.2% 9.2% 246.6% 33.3%
GRDN 17.9% 3.4% 24.8% 20.2%
MD $1.77B 11.0 -4.9% 8.6% 20.3%
ADUS 20.6 23.2%
WGS
ASTH $1.21B 53.9 56.4% 0.71% 3.0%
AGL $7.14B -2.1% -6.6% -146.1%
OMDA $922M -45.1 53.2% -4.9% -5.8% 65.7%
INNV $500M -16.8 11.8% -3.5% -12.0% 18.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 18
Annual Income Statement data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +14446.6% $727M $661M $592M $510M $484M $444M $409M $277M $240M $232M $5M $5M
Cost of Revenue 12-point trend, +791.0% $413M $370M $347M $322M $297M $259M $212M $149M $138M $134M $56M $46M
Gross Profit 12-point trend, +672.0% $314M $290M $245M $188M $187M $186M $197M $127M $102M $98M $44M $41M
R&D Expense 12-point trend, +1278.8% $37M $31M $27M $30M $22M $8M $8M $3M $4M $5M $4M $3M
SG&A Expense 12-point trend, +1048.1% $273M $260M $243M $243M $221M $144M $128M $85M $70M $64M $34M $24M
Operating Expenses 12-point trend, +1017.5% $430M $382M $352M $346M $306M $200M $184M $117M $99M $96M $49M $38M
Operating Income 12-point trend, -5324.6% $-116M $-92M $-108M $-158M $-119M $-14M $13M $10M $3M $2M $-6M $2M
Interest Expense 9-point trend, +601.2% · · $7M $8M $8M $7M $4M $6M $6M · $854.0K $985.0K
Interest Income 5-point trend, +189.0% $9M $18M $17M $6M $3M · · · · · · ·
Other Non-op 12-point trend, +428.6% $296.0K $-379.0K $644.0K $-213.0K $-499.0K $8M $-5M $14.0K $-12.0K $0 $2M $56.0K
Pretax Income 12-point trend, -8654.5% $-110M $-81M $-97M $-159M $-15M $-14M $4M $4M $-3M $-8M $-4M $1M
Income Tax 12-point trend, -1528.7% $-2M $-2M $-9M $-15M $-7M $-18M $-4M $1M $-2M $-2M $-2M $157.0K
Net Income 12-point trend, -9642.8% $-108M $-79M $-88M $-144M $-8M $4M $8M $3M $-396.0K $-6M $-3M $1M
EPS (Basic) 2-point trend, -300.0% · · · · · · · · · · $-0.04 $0.02
EPS (Diluted) 2-point trend, -300.0% · · · · · · · · · · $-0.04 $0.02
Shares (Basic) 12-point trend, +139.5% 128,101,000 126,658,000 125,502,000 124,217,000 119,962,000 108,579,000 100,470,000 85,618,000 79,426,000 77,542,000 60,526,000 53,483,000
Shares (Diluted) 12-point trend, +128.7% 128,101,000 126,658,000 125,502,000 124,217,000 119,962,000 111,794,000 103,615,000 91,568,000 79,426,000 77,542,000 60,526,000 56,016,000
EBITDA 9-point trend, -1956.5% $-116M $-92M $-108M $-158M $-119M $-14M $13M · $2M · $-6M ·
Balance Sheet 29
Annual Balance Sheet data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +373.8% $160M $367M $342M $263M $317M $229M $173M $10M $13M $13M $23M $34M
Receivables 12-point trend, +677.7% $159M $151M $131M $120M $112M $107M $94M $77M $60M $56M $49M $20M
Inventory 12-point trend, +992.0% $29M $27M $24M $24M $23M $30M $14M $9M $7M $6M $5M $3M
Prepaid Expense 12-point trend, +1779.3% $21M $20M $18M $15M $12M $12M $6M $8M $5M $5M $5M $1M
Other Current Assets 9-point trend, +641.0% $7M $12M $8M $8M $8M $5M $3M $561.0K $1M · · ·
Current Assets 12-point trend, +540.6% $376M $596M $597M $605M $682M $449M $291M $104M $86M $79M $82M $59M
PP&E (Net) 12-point trend, +462.5% $85M $94M $92M $102M $109M $86M $64M $61M $37M $34M $35M $15M
PP&E (Gross) 12-point trend, +742.0% $294M $284M $250M $234M $219M $179M $133M $111M $77M $61M $61M $35M
Accum. Depreciation 12-point trend, +954.7% $209M $190M $158M $132M $110M $93M $69M $50M $41M $27M $27M $20M
Goodwill 12-point trend, +17801.8% $524M $523M $523M $523M $527M $211M $199M $198M $147M $147M $147M $3M
Intangibles 12-point trend, +6702.7% $287M $340M $373M $408M $442M $121M $127M $140M $74M $77M $88M $4M
Other Non-current Assets 12-point trend, +6524.1% $9M $6M $5M $5M $7M $5M $3M $3M $891.0K $174.0K $129.0K $141.0K
Total Assets 12-point trend, +1576.6% $1.36B $1.64B $1.68B $1.74B $1.87B $988M $710M $505M $344M $337M $351M $81M
Accounts Payable 12-point trend, +266.9% $23M $22M $20M $21M $18M $25M $20M $18M $10M $17M $12M $6M
Accrued Liabilities · · · · · · · · · · · $1M
Current Liabilities 12-point trend, +503.8% $88M $301M $96M $90M $87M $73M $64M $61M $36M $38M $40M $15M
Capital Leases 12-point trend, +1109.7% $63M $61M $68M $69M $72M $42M $24M $5M $5M $5M $5M $5M
Deferred Tax 11-point trend, +2119.1% $18M $22M $24M $35M $55M $5M $16M $22M $7M · $16M $821.0K
Other Non-current Liabilities 9-point trend, +4155.1% $12M $12M $13M $13M $14M $4M $4M $3M $283.0K · · ·
Total Liabilities 12-point trend, +2427.7% $523M $736M $740M $742M $762M $294M $202M $185M $140M $151M $113M $21M
Long-term Debt 7-point trend, +521.3% $342M $541M $538M · · · · $102M $97M $98M $55M ·
Total Debt 5-point trend, +547.4% $342M $541M · · · $0 · · $95M · $53M ·
Common Stock · · · · · · · · · · · $60.0K
Retained Earnings 12-point trend, -2135.4% $-434M $-326M $-247M $-159M $-15M $-7M $-11M $-19M $-58M $-52M $-22M $-19M
Treasury Stock $0 · · · · · · · · · · ·
AOCI 9-point trend, -98.5% $4.0K $-206.0K $-2M $-4M $-638.0K $10.0K $-2M $-579.0K $274.0K · · ·
Stockholders' Equity 12-point trend, +1284.9% $837M $902M $942M $998M $1.11B $694M $507M $320M $172M $162M $209M $60M
Liabilities + Equity 12-point trend, +1576.6% $1.36B $1.64B $1.68B $1.74B $1.87B $988M $710M $505M $344M $337M $351M $81M
Shares Outstanding 12-point trend, +114.1% 128,989,152 128,145,333 127,369,142 126,913,992 124,107,500 112,075,474 104,781,236 94,465,440 80,462,574 78,571,158 75,820,307 60,242,818
Cash Flow 15
Annual Cash Flow data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
D&A 7-point trend, +384.6% · · · · · $26M $20M $16M $16M $16M $7M $5M
Stock-based Comp 12-point trend, +6345.6% $41M $33M $25M $25M $22M $10M $10M $7M $6M $5M $3M $641.0K
Deferred Tax 11-point trend, -47.3% $-3M $-3M $-10M $-15M $-7M $-18M $-4M $2M $-2M $-2M $-2M ·
Amort. of Intangibles 12-point trend, +10663.4% $32M $33M $35M $34M $23M $10M $10M $6M $7M $7M $412.0K $295.0K
Restructuring 6-point trend, +0.00 $0 $7M $11M $5M $0 $0 · · · · · ·
Operating Cash Flow 12-point trend, -44.7% $5M $7M $-2M $-66M $-27M $1M $23M $45M $18M $21M $6M $9M
CapEx 12-point trend, +616.0% $27M $41M $29M $31M $64M $29M $20M $14M $14M $8M $2M $4M
Investing Cash Flow 9-point trend, +9.9% $-12M $13M $77M $517.0K $-632M $-159M $-20M $-140M $-14M · · ·
Stock Issued 10-point trend, -97.2% $962.0K $5M $5M $13M $15M $20M $11M $9M $3M · · $34M
Net Stock Activity 7-point trend, -91.4% $962.0K $5M $5M $13M $15M $20M $11M · · · · ·
Financing Cash Flow 9-point trend, -4791.0% $-200M $5M $5M $12M $725M $236M $159M $92M $-4M · · ·
Net Change in Cash 7-point trend, +169.0% · · · · · $78M $163M $-3M $296.0K $-11M $-10M $29M
Taxes Paid 10-point trend, +77.6% $515.0K $207.0K $175.0K $180.0K $148.0K $246.0K $319.0K $-31.0K $284.0K $290.0K · ·
Free Cash Flow 9-point trend, -621.3% $-22M $-34M $-31M $-97M $-91M $-28M $3M · $4M · $4M ·
Levered FCF 6-point trend, -1100.1% · · $-37M $-98M $-94M $-26M $-5M · · · $4M ·
Profitability 8
Annual Profitability data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 8-point trend, -95.1% 43.2% 43.9% 41.3% 36.9% 38.6% 41.8% 48.1% · · · 875.1% ·
Operating Margin 8-point trend, +85.9% -15.9% -13.9% -18.2% -30.9% -24.5% -3.1% 3.2% · · · -112.7% ·
Net Margin 8-point trend, +70.7% -14.8% -11.9% -14.9% -28.3% -1.7% 0.94% 2.0% · · · -50.7% ·
Pretax Margin 8-point trend, +83.1% -15.2% -12.2% -16.4% -31.3% -3.1% -3.2% 0.89% · · · -89.8% ·
EBITDA Margin 8-point trend, +85.9% -15.9% -13.9% -18.2% -30.9% -24.5% -3.1% 3.2% · · · -112.7% ·
ROA 9-point trend, -538.1% -7.2% -4.7% -5.1% -8.0% -0.58% 0.49% 1.3% · -0.25% · -1.1% ·
ROE 9-point trend, -579.8% -12.8% -8.7% -9.3% -14.3% -0.74% 0.61% 1.6% · -0.50% · -1.9% ·
ROIC 9-point trend, -695.9% -9.6% -6.2% -10.4% -14.3% -5.9% 0.60% 5.6% · 0.21% · -1.2% ·
Liquidity & Solvency 5
Annual Liquidity & Solvency data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 9-point trend, +72.4% 4.3 2.0 6.2 6.7 7.8 6.1 4.5 · 2.4 · 2.5 ·
Quick Ratio 9-point trend, +99.9% 3.6 1.7 4.9 4.3 4.9 4.6 4.2 · 2.1 · 1.8 ·
Debt / Equity 5-point trend, +62.1% 0.4 0.6 · · · 0.0 · · 0.5 · 0.3 ·
LT Debt / Equity 4-point trend, +63.8% 0.4 0.4 · · · · · · 0.5 · 0.2 ·
Interest Coverage 6-point trend, -136.4% · · -15.6 -104.7 -23.4 -2.0 3.5 · · · -6.6 ·
Efficiency 3
Annual Efficiency data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 8-point trend, +2075.8% 0.5 0.4 0.3 0.3 0.3 0.5 0.7 · · · 0.0 ·
Inventory Turnover 9-point trend, +2.9% 14.9 14.6 14.3 13.5 11.2 11.8 18.4 · 20.1 · 14.5 ·
Receivables Turnover 8-point trend, +3158.7% 4.7 4.7 4.7 4.4 4.4 4.4 4.8 · · · 0.1 ·
Per Share 5
Annual Per Share data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 9-point trend, +136.3% $6.53 $7.08 $7.42 $8.04 $9.89 $6.63 $5.37 · $2.15 · $2.76 ·
Revenue / Share 8-point trend, +6773.8% $5.68 $5.22 $4.71 $4.10 $4.04 $3.98 $3.95 · · · $0.08 ·
Cash Flow / Share 9-point trend, -61.4% $0.04 $0.06 $-0.02 $-0.53 $-0.22 $0.01 $0.23 · $0.23 · $0.11 ·
Cash / Share 9-point trend, +303.2% $1.25 $2.88 $2.70 $2.12 $2.83 $2.18 $1.83 · $0.16 · $0.31 ·
EPS (TTM) 12-point trend, -1300.0% $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.24 $-0.04 $0.02
Growth Rates 3
Annual Growth Rates data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +12.7% 10.1% 11.7% 16.1% 5.2% 9.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +25.7% 12.6% 10.9% 10.0% · · · · · · · · ·
Revenue CAGR 5Y 10.3% · · · · · · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for NEO
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +14446.6% $727M $661M $592M $510M $484M $444M $409M $277M $240M $232M $5M $5M
Net Income TTM 12-point trend, -9642.8% $-108M $-79M $-88M $-144M $-8M $4M $8M $3M $-396.0K $-6M $-3M $1M
Market Cap 9-point trend, +152.6% $1.51B $2.10B $2.05B $1.15B $3.82B $5.64B $2.76B · $713M · $597M ·
Enterprise Value 5-point trend, +169.8% $1.69B $2.27B · · · $5.41B · · $795M · $626M ·
P/E 12-point trend, -123.5% -49.0 -68.7 -67.4 -38.5 -142.2 -224.3 -121.9 -52.5 -36.9 -35.7 -196.8 208.5
P/S 9-point trend, -98.3% 2.1 3.2 3.5 2.2 7.9 12.7 6.8 · 3.0 · 119.3 ·
P/B 9-point trend, -36.8% 1.8 2.3 2.2 1.1 3.5 8.1 5.4 · 4.1 · 2.8 ·
P / Tangible Book 6-point trend, +277.0% 58.7 52.6 45.0 17.1 27.5 15.6 · · · · · ·
P / Cash Flow 9-point trend, +208.7% 288.1 298.9 -1051.4 -17.4 -143.1 3864.0 118.2 · 39.5 · 93.3 ·
P / FCF 9-point trend, -148.5% -69.2 -61.7 -66.9 -11.8 -42.1 -204.1 827.3 · 164.0 · 142.8 ·
EV / EBITDA 5-point trend, +86.9% -14.6 -24.7 · · · -386.8 · · 342.1 · -111.1 ·
EV / FCF 5-point trend, -151.8% -77.6 -66.8 · · · -195.9 · · 182.9 · 149.9 ·
EV / Revenue 5-point trend, -98.1% 2.3 3.4 · · · 12.2 · · 3.3 · 125.2 ·
Earnings Yield 12-point trend, -525.0% -2.0% -1.5% -1.5% -2.6% -0.70% -0.45% -0.82% -1.9% -2.7% -2.8% -0.51% 0.48%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $727M$661M$592M$510M$484M
Gross Margin % 43.2%43.9%41.3%36.9%38.6%
Operating Margin % -15.9%-13.9%-18.2%-30.9%-24.5%
Net Income $-108M$-79M$-88M$-144M$-8M
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.40.6
Current Ratio 4.32.06.26.77.8
Quick Ratio 3.61.74.94.34.9
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-22M$-34M$-31M$-97M$-91M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 299 filers · $1.8B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
64 (+22 vs prior Q) 38 (+1 vs prior Q) 93 (+20 vs prior Q) 59 (-26 vs prior Q) +33.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
First Light Asset Management, LLC $179,158,241 12,279,523 9.76% Shares
VANGUARD GROUP INC $150,953,759 12,836,204 8.22% Shares
FIRST TRUST ADVISORS LP $147,552,477 10,113,261 8.04% Shares
Greenhouse Funds LLLP $125,097,724 8,574,210 6.82% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $117,615,272 8,061,362 6.41% Shares
VANGUARD CAPITAL MANAGEMENT LLC $84,082,418 5,763,017 4.58% Shares
STATE STREET CORP $78,257,609 5,363,784 4.26% Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $73,501,000 5,037,787 4.00% Shares
BRAIDWELL LP $71,756,567 4,918,202 3.91% Shares
SCHRODER INVESTMENT MANAGEMENT GROUP $61,886,083 4,342,883 3.37% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $50,558,727 3,465,300 2.75% Call option
MILLENNIUM MANAGEMENT LLC $44,930,518 3,079,542 2.45% Shares
TORONTO DOMINION BANK $43,770,000 3,000,000 2.38% Call option
GEODE CAPITAL MANAGEMENT, LLC $42,933,596 2,942,009 2.34% Shares
Driehaus Capital Management LLC $36,604,049 2,508,845 1.99% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $34,896,129 2,391,784 1.90% Shares
AMERICAN CAPITAL MANAGEMENT INC $32,648,145 2,237,707 1.78% Shares
DIMENSIONAL FUND ADVISORS LP $32,593,724 2,233,977 1.78% Shares
UBS Group AG $32,581,659 2,233,150 1.78% Call option
LOOMIS SAYLES & CO L P $30,838,504 2,113,674 1.68% Shares
Aberdeen Group plc $28,180,950 1,931,525 1.54% Shares
D. E. Shaw & Co., Inc. $27,938,858 1,914,932 1.52% Shares
GLENMEDE TRUST CO NA $20,985,657 1,438,359 1.14% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $17,689,018 1,212,407 0.96% Shares
SEGALL BRYANT & HAMILL, LLC $15,850,518 1,086,396 0.86% Shares
VANGUARD FIDUCIARY TRUST CO $12,685,640 869,475 0.69% Shares
AQR CAPITAL MANAGEMENT LLC $11,918,848 816,919 0.65% Shares
SAMLYN CAPITAL, LLC $11,869,359 813,527 0.65% Shares
Connor, Clark & Lunn Investment Management Ltd. $11,707,337 802,422 0.64% Shares
Glenmede Investment Management, LP $11,359,995 1,471,502 0.62% Shares
PRINCIPAL FINANCIAL GROUP INC $9,141,555 626,563 0.50% Shares
HighMark Wealth Management LLC $8,936,871 612,534 0.49% Shares
JUPITER ASSET MANAGEMENT LTD $7,841,935 537,487 0.43% Shares
Public Sector Pension Investment Board $6,526,545 447,330 0.36% Shares
Trexquant Investment LP $6,358,074 435,783 0.35% Shares
GOLDMAN SACHS GROUP INC $5,559,884 381,075 0.30% Shares
Bank of New York Mellon Corp $5,554,938 380,736 0.30% Shares
Granite Investment Partners, LLC $5,181,507 355,141 0.28% Shares
RHUMBLINE ADVISERS $4,624,054 316,935 0.25% Shares
AMERIPRISE FINANCIAL INC $4,623,822 316,917 0.25% Shares
Weiss Asset Management LP $4,171,558 285,919 0.23% Shares
Swiss National Bank $3,800,695 260,500 0.21% Shares
SUSQUEHANNA ADVISORS GROUP, INC. $3,770,056 258,400 0.21% Shares
STATE OF WISCONSIN INVESTMENT BOARD $3,680,109 252,235 0.20% Shares
Universal- Beteiligungs- und Servicegesellschaft mbH $3,455,481 236,839 0.19% Shares
FMR LLC $3,409,026 233,655 0.19% Shares
Squarepoint Ops LLC $3,239,505 222,036 0.18% Shares
ExodusPoint Capital Management, LP $3,128,811 214,449 0.17% Shares
Legal & General Group Plc $2,907,700 199,294 0.16% Shares
PEAK6 LLC $2,651,003 181,700 0.14% Call option
FEDERATED HERMES, INC. $2,510,064 172,040 0.14% Shares
BANK OF AMERICA CORP /DE/ $2,221,357 152,252 0.12% Shares
WHITE PINE CAPITAL LLC $2,167,184 148,539 0.12% Shares
PRUDENTIAL FINANCIAL INC $2,017,870 138,305 0.11% Shares
AMERICAN CENTURY COMPANIES INC $1,987,158 136,200 0.11% Shares
BlackRock, Inc. $1,962,691 134,523 0.11% Shares
WELLS FARGO & COMPANY/MN $1,943,067 133,178 0.11% Shares
STEELHEAD PARTNERS LLC $1,885,028 129,200 0.10% Shares
BNP PARIBAS FINANCIAL MARKETS $1,787,859 122,540 0.10% Shares
Greenhouse Funds LLLP $1,689,522 115,800 0.09% Call option
PERKINS CAPITAL MANAGEMENT INC $1,605,483 110,040 0.09% Shares
GABELLI FUNDS LLC $1,597,605 109,500 0.09% Shares
ARISTEIA CAPITAL, L.L.C. $1,571,343 107,700 0.09% Shares
IEQ CAPITAL, LLC $1,524,305 104,476 0.08% Shares
Verition Fund Management LLC $1,477,019 101,235 0.08% Shares
GAMCO INVESTORS, INC. ET AL $1,459,000 100,000 0.08% Shares
Fernwood Investment Management, LLC $1,453,536 88,200 0.08% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $1,440,244 194,103 0.08% Shares
XTX Topco Ltd $1,413,552 96,885 0.08% Shares
VANGUARD ASSET MANAGEMENT, Ltd $1,403,354 96,186 0.08% Shares
CITADEL ADVISORS LLC $1,324,772 90,800 0.07% Call option
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,279,178 87,675 0.07% Shares
Curi Capital, LLC $1,256,666 86,132 0.07% Shares
MFG WEALTH MANAGEMENT, INC. $1,217,711 83,462 0.07% Shares
ALLIANCEBERNSTEIN L.P. $1,189,723 160,340 0.06% Shares
MetLife Investment Management, LLC $1,120,293 76,785 0.06% Shares
Mariner, LLC $1,117,405 76,587 0.06% Shares
Zurcher Kantonalbank (Zurich Cantonalbank) $1,039,421 71,242 0.06% Shares
TWO SIGMA ADVISERS, LP $983,136 83,600 0.05% Shares
Russell Investments Group, Ltd. $967,068 66,283 0.05% Shares
VOYA INVESTMENT MANAGEMENT LLC $962,429 65,965 0.05% Shares
MORGAN STANLEY $954,638 65,431 0.05% Shares
Quantinno Capital Management LP $945,359 64,795 0.05% Shares
Illinois Municipal Retirement Fund $932,520 63,915 0.05% Shares
WINTON GROUP Ltd $924,700 63,379 0.05% Shares
Quantbot Technologies LP $922,540 63,231 0.05% Shares
CHOREO, LLC $889,115 60,940 0.05% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $884,373 60,615 0.05% Shares
MOODY NATIONAL BANK TRUST DIVISION $860,445 58,975 0.05% Shares
Louisiana State Employees Retirement System $833,089 57,100 0.05% Shares
SIMPLEX TRADING, LLC $796,453 54,589 0.04% Shares
JANE STREET GROUP, LLC $786,401 53,900 0.04% Call option
MANUFACTURERS LIFE INSURANCE COMPANY, THE $786,109 53,880 0.04% Shares
Teton Advisors, LLC $774,729 53,100 0.04% Shares
Invesco Ltd. $766,515 52,537 0.04% Shares
COMMERCE BANK $764,632 52,408 0.04% Shares
Vanguard Global Advisers, LLC $741,070 50,793 0.04% Shares
BARD ASSOCIATES INC $683,761 46,865 0.04% Shares
Alamea Verwaltungs GmbH $683,702 46,861 0.04% Shares
NEW YORK STATE COMMON RETIREMENT FUND $674,467 46,228 0.04% Shares

Company insiders 52 insiders · 30 officers · 23 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Anthony P. Zook Chief Executive Officer June 1, 2025 M 20,166 0 0 $0
Christopher M Smith Chief Executive Officer Feb. 23, 2025 M 641,585 0 0 $0
Mark Mallon Chief Executive Officer March 1, 2022 A 368,051 0 0 $0
Jeffrey Scott Sherman Chief Financial Officer May 11, 2025 M 168,332 0 0 $0
William Bonello Chief Financial Officer April 28, 2022 M 191,548 0 0 $0
Sharon Virag Chief Financial Officer March 1, 2019 A 10,944 0 0 $0
Vishal Sikri President Advanced Diagnostics Feb. 23, 2024 A 148,455 0 0 $0
David Sholehvar President, Clinical Services Aug. 1, 2022 A 43,216 0 0 $0
George Cardoza President & COO, Lab Ops March 2, 2022 F 244,157 0 0 $0
Gina M Wallar President, Pharma Services March 1, 2022 A 33,443 0 0 $0
Clive Morris President of Inivata Dec. 30, 2021 A 41,280 0 0 $0
Robert J. Shovlin President, Clinical Services May 25, 2021 M 150,101 0 0 $0
Warren Stone Pres & Chief Operating Officer May 11, 2025 M 108,280 0 0 $0
Alicia C Olivo EVP, GC & Business Development Sept. 1, 2025 F 47,940 0 0 $0
Melody Harris Chf Ops Off, Pres, Informatics Feb. 23, 2025 M 109,755 0 0 $0
Shashikant Kulkarni Chief Scientific Officer April 1, 2023 F 82,673 0 0 $0
Cynthia J Dieter Chief Accounting Officer March 2, 2023 F 29,765 0 0 $0
Douglas Matthew Brown Chief Strategy Officer April 1, 2022 A 158,684 0 0 $0
Halley E Gilbert Chief Legal Officer March 1, 2022 A 147,396 0 0 $0
Kathryn B Mckenzie Chief Sustainability/Risk Ofcr Jan. 11, 2022 M 49,361 0 0 $0
Jennifer Balliet VP and Chief Culture Officer Dec. 30, 2021 A 48,615 0 0 $0
Lawrence Martin Weiss Chief Medical Officer April 22, 2021 M 130,847 0 0 $0
Denise E Pedulla General Counsel March 2, 2021 A 60,643 0 0 $0
Steven G. Brodie VP - Pharma Operations Oct. 22, 2018 M 45,953 0 0 $0
Steven A Ross CIO May 10, 2018 X 4,500 0 0 $0
Maher Albitar Chief Medical Officer May 25, 2017 A 60,692 0 0 $0
Mark Alan Machulcz Vice President of Operations Jan. 28, 2016 A 0 0 $0
Robert H. Horel Vice President GM PathLogic Dec. 29, 2015 X 51,218 0 0 $0
Robert P Gasparini Chief Science Officer May 22, 2014 X 8,439 0 0 $0
Mark W Smits Chief Commercial Officer May 18, 2011 M 0 0 0 $0
Carolyn S Starrett Director June 23, 2026 A 0 0 $0
Lynn A. Tetrault Director June 15, 2026 S 86,115 0 2 $-118,824
Marjorie C Green Director June 1, 2026 A 22,964 0 0 $0
Neil Gunn Director June 1, 2026 A 51,177 0 0 $0
Michael Aaron Kelly Director June 1, 2026 A 67,086 0 0 $0
David Brian Perez Director June 1, 2026 A 56,967 0 0 $0
John P. Kenny Director June 1, 2026 A 5,893 0 0 $0
Stephen M Kanovsky Director June 1, 2026 A 75,421 0 0 $0
Felicia Williams Director June 1, 2026 A 30,237 0 0 $0
Elizabeth Floegel Director June 1, 2025 A 23,590 0 0 $0
Alison L. Hannah Director June 1, 2025 M 131,023 0 0 $0
Bruce K Crowther Director Aug. 10, 2023 A 65,120 0 0 $0
Rachel A Stahler Director June 10, 2022 A 21,335 0 0 $0
David Daly Director June 10, 2022 A 17,179 0 0 $0
Kevin C Johnson Director Dec. 22, 2021 M 37,398 0 0 $0
Douglas M Van Oort Director Aug. 1, 2021 F 2,468,797 0 0 $0
Steven C Jones Director Jan. 7, 2021 M 90,218 0 0 $0
Raymond R Hipp Director Nov. 16, 2020 S 66,800 0 0 $0
William J Robison Director May 25, 2017 A 183,348 0 0 $0
Michael T Dent Director Dec. 4, 2014 S 1,384,150 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
IRS IDENTIFICATION NO. NeoGenomics, Inc. April 12, 2007 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 62 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PTH · Invesco Exchange-Traded Fund Trust 1.12% 167,212 SH Aug. 8, 2026 Daily
PSCH · Invesco Exchange-Traded Fund Trust … 1.09% 113,008 SH Aug. 8, 2026 Daily
LFSC · RBB Fund, Inc. 0.43% 43,071 NS May 31, 2026 N-PORT
IHF · iShares Trust 0.31% 243,554 SH Aug. 8, 2026 Daily
FYC · First Trust Exchange-Traded AlphaDE… 0.14% 154,408 NS April 30, 2026 N-PORT
IJT · iShares Trust 0.13% 700,692 SH Aug. 8, 2026 Daily
XJR · iShares Trust 0.13% 15,435 SH Aug. 8, 2026 Daily
QVMS · Invesco Exchange-Traded Fund Trust … 0.12% 19,262 SH Aug. 8, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.12% 211,878 SH Aug. 8, 2026 Daily
VIOG · VANGUARD ADMIRAL FUNDS 0.12% 89,895 SH Aug. 8, 2026 Daily
IWN · iShares Trust 0.12% 1,117,630 SH Aug. 8, 2026 Daily
IJR · iShares Trust 0.11% 7,947,524 SH Aug. 8, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.11% 104,297 SH Aug. 8, 2026 Daily
VIOO · VANGUARD ADMIRAL FUNDS 0.10% 455,144 SH Aug. 8, 2026 Daily
NUSC · Nushares ETF Trust 0.10% 135,666 NS April 30, 2026 N-PORT
IJS · iShares Trust 0.09% 489,210 SH Aug. 8, 2026 Daily
VIOV · VANGUARD ADMIRAL FUNDS 0.09% 116,046 SH Aug. 8, 2026 Daily
ESML · iShares Trust 0.09% 158,897 SH Aug. 8, 2026 Daily
FYX · First Trust Exchange-Traded AlphaDE… 0.07% 93,313 NS April 30, 2026 N-PORT
GINN · Goldman Sachs ETF Trust 0.07% 13,856 NS May 31, 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0.07% 85,056 SH Aug. 8, 2026 Daily
IWM · iShares Trust 0.06% 3,340,583 SH Aug. 8, 2026 Daily
ISCG · iShares Trust 0.06% 40,428 SH Aug. 8, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.06% 49,165 NS April 30, 2026 N-PORT
SAA · ProShares Trust 0.06% 1,546 NS May 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.06% 757,699 SH Aug. 8, 2026 Daily
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0.05% 33,295 NS April 30, 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0.05% 1,728,845 SH Aug. 8, 2026 Daily
AVSC · AMERICAN CENTURY ETF TRUST 0.04% 106,278 NS May 31, 2026 N-PORT
RSSL · Global X Funds 0.04% 55,874 NS April 30, 2026 N-PORT
ITWO · ProShares Trust 0.03% 6,071 NS May 31, 2026 N-PORT
ISCB · iShares Trust 0.03% 5,811 SH Aug. 8, 2026 Daily
VHT · VANGUARD WORLD FUND 0.03% 388,986 SH Aug. 8, 2026 Daily
SCHA · SCHWAB STRATEGIC TRUST 0.03% 628,556 NS May 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.03% 425,333 NS April 30, 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.03% 14,399 NS April 30, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.02% 1,492,431 SH Aug. 8, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.02% 2,990,594 SH Aug. 8, 2026 Daily
UWM · ProShares Trust 0.02% 4,748 NS May 31, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.02% 60,531 NS April 30, 2026 N-PORT
WSML · iShares Trust 0.02% 7,690 SH Aug. 8, 2026 Daily
SMLF · iShares Trust 0.02% 45,201 SH Aug. 8, 2026 Daily
URTY · ProShares Trust 0.01% 4,804 NS May 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 5,288 NS April 30, 2026 N-PORT
IWO · iShares Trust 0.01% 113,167 SH Aug. 8, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.01% 12,627 SH Aug. 8, 2026 Daily
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.01% 5,219 NS May 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.01% 339,840 NS April 30, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.01% 15,340 NS April 30, 2026 N-PORT
HDG · ProShares Trust 0.01% 121 NS May 31, 2026 N-PORT